Navigation Links
The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
Date:9/13/2007

Leading thinkers and senior executives from companies and government

organizations will gather for 3rd Annual Personalized Medicine event

produced by Burrill Life Sciences Media Group

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- In the foreseeable future a trip to the doctor's office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor's advice. While we can see the future of health care, we are still a tantalizing long way away from embracing it. There are many scientific, legal, ethical, regulatory and policy challenges that have to be addressed before personalized medicine becomes a reality in 21st century medicine.

The 3rd Burrill Personalized Medicine Meeting (San Francisco, November 12-13, 2007), hosted by Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, provides a "window" into these new realities with detailed discussions and analysis on the whole spectrum of personalized medicine -- from prediction to prevention and how they will have a major impact on the delivery of health care.

Some of the leading thinkers and senior executives from companies and government organizations will be participating in this event. Sessions include:

-- Personalized Medicine in the Clinic

-- How Science and Technology is Accelerating the Pace of Biomarker

Development

-- Targeted Treatments vs. The "one size fits all" Blockbuster

-- Pharmacogenomics comes of Age

-- The increasing role of Diagnostics in Personalized Medicine

-- Patient-centric Medicine -- Personalized Medicine from the Patient's

Point of View

-- The Regulatory Environment: The FDA's Perspective

The Burrill Personalized Medicine Meeting has established itself as a "must attend" event that not only embraces the current state of personalized medicine but also the business, finance, regulatory and reimbursement issues that are linked with this rapidly evolving field. It provides a forum for education, discussion and networking with the leaders in this field.

About Burrill Life Sciences Media Group

The Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces worldwide life sciences conferences, and leading publications including an annual book on the "State of the Industry, the 21st Edition is Biotech 2007: Life Sciences-A Global Transformation; a series of bio-intelligence reports including the Personalized Medicine Report, and The Journal of Life Sciences, in association with the California Healthcare Institute.

For further information:

Website: http://www.personalizedmedicinemeeting.com


'/>"/>
SOURCE Burrill Life Sciences Media Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. Winner of Burrill competition courted by North Carolina investors
7. Technology and business merge at UW Burrill Competition
8. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
9. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
10. Students Win Burrill Competition With Plan for Renewable Energy
11. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Calif. , March 24, 2017   Sienna ... and aesthetics company, today announced that Richard Peterson ... effective March 24.   Peterson, who brings more ... John Smither , who is retiring at the ... in an advisory capacity. Peterson joins Sienna from Novan, ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):